Technical Analysis for ANVS - Annovis Bio, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Up | Up | Up |
| Historical ANVS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| Multiple of Ten Bullish | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Shooting Star Candlestick | Bearish | 3.89% | |
| Lizard Bearish | Bearish Day Trade Setup | 3.89% | |
| New 52 Week Closing High | Bullish | 3.89% | |
| Pocket Pivot | Bullish Swing Setup | 3.89% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 60 Minute Opening Range Breakout | about 2 hours ago | |
| Up 3% | about 8 hours ago | |
| Up 2% | about 8 hours ago | |
| Up 1% | about 8 hours ago | |
| 2x Volume Pace | about 8 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alzheimer's Disease Mild Novi Amyloid Nervous System Neurodegeneration Psychiatric Diagnosis Alzheimer's Cognitive Disorders Neurodegenerative Disorders Cognitive Impairment Learning Disabilities Neuroprotection Gladstone Institutes Parkinson's Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alzheimer's Disease Mild Novi Amyloid Nervous System Neurodegeneration Psychiatric Diagnosis Alzheimer's Cognitive Disorders Neurodegenerative Disorders Cognitive Impairment Learning Disabilities Neuroprotection Gladstone Institutes Parkinson's Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.2 |
| 52 Week Low | 2.418 |
| Average Volume | 70,983 |
| 200-Day Moving Average | 5.33 |
| 50-Day Moving Average | 6.79 |
| 20-Day Moving Average | 8.61 |
| 10-Day Moving Average | 9.74 |
| Average True Range | 0.68 |
| ADX | 63.73 |
| +DI | 38.68 |
| -DI | 6.18 |
| Chandelier Exit (Long, 3 ATRs ) | 9.16 |
| Chandelier Exit (Short, 3 ATRs ) | 8.06 |
| Upper Bollinger Band | 11.30 |
| Lower Bollinger Band | 5.93 |
| Percent B (%b) | 0.86 |
| BandWidth | 62.37 |
| MACD Line | 1.07 |
| MACD Signal Line | 0.97 |
| MACD Histogram | 0.1038 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.59 | ||||
| Resistance 3 (R3) | 11.51 | 11.08 | 11.42 | ||
| Resistance 2 (R2) | 11.08 | 10.82 | 11.12 | 11.36 | |
| Resistance 1 (R1) | 10.81 | 10.65 | 10.95 | 10.89 | 11.30 |
| Pivot Point | 10.39 | 10.39 | 10.45 | 10.43 | 10.39 |
| Support 1 (S1) | 10.12 | 10.12 | 10.25 | 10.20 | 9.79 |
| Support 2 (S2) | 9.69 | 9.96 | 9.73 | 9.73 | |
| Support 3 (S3) | 9.42 | 9.69 | 9.67 | ||
| Support 4 (S4) | 9.50 |
